Athos Capital Ltd - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
Athos Capital Ltd ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$110,184,000
+157.1%
930,529
+156.4%
18.40%
+55.7%
Q4 2020$42,863,000
+41.3%
362,909
+32.9%
11.81%
-19.1%
Q3 2020$30,345,000
+10.1%
273,032
+1.2%
14.60%
-22.5%
Q2 2020$27,571,000
+1880.7%
269,832
+1991.7%
18.83%
+1851.3%
Q1 2020$1,392,000
+44.2%
12,900
+55.6%
0.96%
+0.3%
Q4 2019$965,000
+1.7%
8,2900.0%0.96%
+3.3%
Q3 2019$949,000
+20.1%
8,2900.0%0.93%
+167.5%
Q2 2019$790,000
+4.5%
8,2900.0%0.35%
-28.5%
Q1 2019$756,000
-11.0%
8,290
-25.9%
0.49%
-42.0%
Q4 2018$849,000
-75.8%
11,190
-68.3%
0.84%
-29.4%
Q2 2018$3,503,00035,2661.19%
Other shareholders

There were no reported owners of CHINA BIOLOGIC PRODS HLDGS I in Q3 2023.

NameSharesValueWeighting ↓
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders